Burning Rock Biotech Limited — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/181c91e6-cc5d-4400-99fe-3cfbbe5c1bc1/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $77.2M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-183377 |
| FY 2024 | $70.7M | 2024-01-01 – 2024-12-31 | evidence 0001193125-25-101753 |
| FY 2023 | $75.7M | 2023-01-01 – 2023-12-31 | evidence 0001193125-24-119655 |
| FY 2022 | $81.7M | 2022-01-01 – 2022-12-31 | evidence 0001193125-23-108289 |
| FY 2021 | $79.7M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-133522 |
| FY 2020 | $65.9M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-090543 |
| FY 2019 | — | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-090543 |
| FY 2018 | — | 2018-01-01 – 2018-12-31 | evidence 0001193125-21-090543 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Burning Rock Biotech Limited — all facts · Net Income · Operating Income